Skip to main content

ANSIRH research highlights 2018

Welcome to ANSIRH's 2018 research highlights page. We are proud to share our major accomplishments from this past year, including publications, media mentions, op-eds and awards. We are also excited to share our plans as we head into 2019.

Publications

In 2018, ANSIRH published 62 peer-reviewed research articles.

Below is a list of links to summaries for selected 2018 publications. To access a full list of our publications, visit our Journal Articles web page.  

Media articles featuring ANSIRH

In 2018, ANSIRH’s research was featured in over 330 media articles in a variety of outlets, including national, political, women, teen, health, and tech. A few highlights are listed below. Please see our website for a curated list of media articles.

Op-eds

In 2018 we placed 22 op-eds and one New York Times letter to the editor (LTE).

Titles and links to selected op-eds and the LTE are listed by author below. For a full list of ANSIRH's 2018 op-eds, contact Jason Harless.

Awards

In 2018, ANSIRH researchers received five of our field’s top awards.

Here is a list of the ANSIRH researchers and their colleagues who received these well-deserved awards. Please join us in congratulating them on their achievements.

Looking forward to 2019

In the coming year, ANSIRH will continue to produce rigorous research that documents the impact of restrictive policies, while we continue to test new strategies to increase access to services and improve people’s reproductive wellbeing. Here’s just a sampling of research projects with important policy implications that we are planning for the year ahead.

  • Document U.S. women’s experiences with self-managed abortion, including their reasons, the methods they use, and clinical outcomes.
  • Conduct an early assessment of the impact of a law in Louisiana that could close most or all of Louisiana’s abortion clinics.
  • Explore the impact of banning the most common method of second-trimester abortion in Texas, if the law goes into effect.
  • Continue to research the safety, effectiveness and acceptability of telemedicine provision of medication abortion, including simplified models of care with optional ultrasound and laboratory testing. The California Home Abortion by Telemedicine (CHAT) Study will be the first of its kind in the U.S. and aims to reduce barriers for people who face geographic, financial, and logistical barriers to obtaining timely abortion care.
  • Explore how the potential for pharmacy dispensing of mifepristone, including via mail-order pharmacy, could change the provision of abortion in the future and improve access to care.
  • Disseminate and explain our research on the potential for increased access to medication abortion on college campuses in California. Legislation may mandate the service to be provided at student health services, which would serve as a model for other states.
  • Discover whether women can accurately determine their eligibility for medication abortion without the help of a clinician.

Follow ANSIRH

Stay up to date on our achievements throughout the year by following us on Twitter and Facebook.